July 2024

Senior Ophthalmology Executive Thomas A. (Tom) Dunlap joins Eyedetec Medical, Inc. as an independent member of the Board of Directors to support the company’s business development and commercialization initiatives within the Optometric and Ophthalmic markets.

  • July 19, 2024September 24, 2024

DANVILLE, CA – Eyedetec Medical, Inc., a medical device company focused on developing innovative, next-generation treatments for dry eye disease, announced the appointment of Tom… Read More »Senior Ophthalmology Executive Thomas A. (Tom) Dunlap joins Eyedetec Medical, Inc. as an independent member of the Board of Directors to support the company’s business development and commercialization initiatives within the Optometric and Ophthalmic markets.

The ELM™ is not currently commercially available for sale in the U.S.

© All rights reserved | privacy-policy | Site by Goalpost Group

Contact Us